1. Home
  2. FNKO vs TTRX Comparison

FNKO vs TTRX Comparison

Compare FNKO & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

HOLD

Current Price

$5.55

Market Cap

301.5M

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$9.43

Market Cap

281.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNKO
TTRX
Founded
2017
2015
Country
United States
United States
Employees
N/A
2
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
301.5M
281.2M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FNKO
TTRX
Price
$5.55
$9.43
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$6.00
$8.00
AVG Volume (30 Days)
571.0K
99.8K
Earning Date
05-07-2026
05-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$908,209,000.00
N/A
Revenue This Year
$4.42
N/A
Revenue Next Year
$6.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$2.57
52 Week High
$6.09
$11.69

Technical Indicators

Market Signals
Indicator
FNKO
TTRX
Relative Strength Index (RSI) 54.16 72.90
Support Level $5.06 $4.40
Resistance Level $5.87 N/A
Average True Range (ATR) 0.29 1.01
MACD -0.02 0.21
Stochastic Oscillator 53.25 64.31

Price Performance

Historical Comparison
FNKO
TTRX

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: